THE IMPACT ON ACCESS TO INNOVATIVE DRUGS OF THE FIRST MANAGED ENTRY AGREEMENTS IN ROMANIA

被引：0
|
作者：
Chiriac, N. D. [1 ]
Radu, P. C. [1 ]
Pravat, M. A. [1 ]
机构：
[1] Roche Romania Srl, Bucharest, Romania
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.908
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP358
引用
收藏
页码：A503 / A503
页数：1
相关论文
共 50 条
  • [21] Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
    Vreman, Rick
    Broekhoff, Thomas
    GM Leufkens, Hubert
    Mantel-Teeuwisse, Aukje
    Goettsch, Wim
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (22) : 1 - 20
  • [22] CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS IN AUSTRALIA
    Robinson, Maxine F.
    Mihalopoulos, Cathrine
    Merlin, Tracy
    Roughead, Elizabeth
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (01) : 46 - 55
  • [23] Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
    Olina Efthymiadou
    Panos Kanavos
    BMC Health Services Research, 22
  • [24] Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
    Efthymiadou, Olina
    Kanavos, Panos
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [25] Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future
    Pauwels, Kim
    Huys, Isabelle
    Vogler, Sabine
    Casteels, Minne
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [26] MANAGED ENTRY AGREEMENTS AND ORPHAN DRUGS: A EUROPEAN COMPARATIVE STUDY (2006-2012)
    Morel, T.
    Arickx, F.
    Befrits, G.
    Siviero, P. D.
    van der Meijden, C. M. J.
    Xoxi, E.
    Simoens, S.
    VALUE IN HEALTH, 2013, 16 (07) : A391 - A391
  • [27] MANAGED ACCESS AGREEMENTS IN THE UK: A DETAILED ANALYSIS OF NICE'S UTILIZATION AND IMPACT ON ACCESS
    Hashim, S.
    Amadori, F.
    Leatham, O.
    VALUE IN HEALTH, 2023, 26 (12) : S373 - S373
  • [28] MEDICAL DEVICES MANAGED ENTRY AGREEMENTS IN FRANCE
    Nguyen-Marzin, M.
    Carval, G.
    Zaccherini, T.
    Rumeau-Pichon, C.
    Bouyoux, P.
    de Joannis, P. E.
    VALUE IN HEALTH, 2020, 23 : S578 - S578
  • [29] A REVIEW OF APPROVED MANAGED ENTRY AGREEMENTS IN SWEDEN
    Pandey, K.
    Sharma, A.
    Singh, B.
    Pandey, S.
    Tripathi, N.
    VALUE IN HEALTH, 2023, 26 (12) : S261 - S261
  • [30] LESSONS LEARNED WITH MANAGED ENTRY AGREEMENTS IN PORTUGAL
    Goncalves, L.
    Caldeira, S.
    Teixeira, M.
    VALUE IN HEALTH, 2017, 20 (09) : A703 - A703
12345